Therapeutic Use Exemption - Procedures
To whom does this apply?
Athletes who have been identified as included in FINA’s Registered Testing Pool and athletes who participate in FINA competitions, may only obtain therapeutic use exemptions in accordance with the rules of FINA.
|Advair (flucticasone and salmeterol)
|Symbicort (budesonide and formoterol)
*when administered by inhalation, and
below a urinary threshold of 1000ng/mL
NB: Please note that the use of oral or intravenous glucocorticosteroids in the emergency treatment of asthma requires a TUE Application Form.
FINA does not automatically recognise TUE from other Anti-Doping Organisation. It only requires a quick review from the FINA TUE Committee (TUEC).
Therefore, in the absence of such automatic recognition, the Athlete shall submit a request for recognition of the TUE to FINA, either via ADAMS or by email at email@example.com.
The request should be accompanied by a copy of the TUE and the original TUE application form and supporting materials referenced at Articles 6.1 and 6.2 of the WADA TUE Standards (unless the Anti-Doping Organization that granted the TUE has already made the TUE and supporting materials available via ADAMS or other system approved by WADA, in accordance with Article 5.4).
The Therapeutic Use Exemption Application Form 2017 is available to download here: TUE FORM
For further information please contact the FINA Office, your national federation or consult the following:
• World Anti-Doping Agency Prohibited List
• WADA Medical Guidelines for Asthma
• WADA International Standard for Therapeutic Use Exemptions